Changes of glucocorticoid receptor expression in the nasal polyps of patients with chronic sinusitis following treatment with glucocorticoid

In Vivo. 2008 Jan-Feb;22(1):37-42.

Abstract

Glucocorticoids (GCs) bind to the cellular glucocorticoid receptors (GRs) to exert anti-inflammatory and immunosuppressive actions. We investigated the changes in the expressions of the two GR isoforms, GR-alpha and GR-beta, in nasal polyps treated with GC. Immunofluorescent staining revealed prominent expression of GR-alpha in the inflammatory cell infiltrate in the polyps obtained from patients with chronic sinusitis and bronchial asthma. Furthermore, while the expression of GR-alpha was significantly reduced following GC treatment, that of GR-beta remained unchanged. The results of real-time PCR also revealed that the prominent expression of GR-alpha mRNA in the polyps decreased following GC treatment, while the expression of GR-beta mRNA remained unchanged. The observations indicate that GR-alpha may play the major role in the inflammation associated with nasal polyps and the ratio of the expression level of GR-beta to that of GR-alpha may serve as a useful index of the clinical efficacy of GC treatment.

MeSH terms

  • Adult
  • Aged
  • Asthma / complications
  • Asthma / drug therapy
  • Asthma / metabolism
  • Betamethasone / therapeutic use*
  • Cell Count
  • Chronic Disease
  • Fluorescent Antibody Technique, Indirect
  • Gene Expression / drug effects
  • Glucocorticoids / therapeutic use*
  • Humans
  • Immunoenzyme Techniques
  • Middle Aged
  • Nasal Polyps / complications
  • Nasal Polyps / drug therapy*
  • Nasal Polyps / metabolism
  • RNA, Messenger / metabolism
  • Receptors, Glucocorticoid / genetics
  • Receptors, Glucocorticoid / metabolism*
  • Sinusitis / complications
  • Sinusitis / drug therapy*
  • Sinusitis / metabolism

Substances

  • Glucocorticoids
  • RNA, Messenger
  • Receptors, Glucocorticoid
  • glucocorticoid receptor alpha
  • glucocorticoid receptor beta
  • Betamethasone